Evolution of the registration regulations for proprietary Chinese medicines in China.
10.1016/S1875-5364(17)30003-1
- Author:
Lin YUAN
1
;
Zhi-Ang WU
2
;
Ming-Li SHAO
3
Author Information
1. School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China.
2. School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China. Electronic address: 13940328503@163.com.
3. School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China. Electronic address: shaoml@cfda.gov.cn.
- Publication Type:Journal Article
- Keywords:
China;
Proprietary Chinese Medicine;
Registration
- MeSH:
China;
Drugs, Chinese Herbal;
history;
Government Regulation;
history;
History, 20th Century;
History, 21st Century;
Humans;
Medicine, Chinese Traditional;
history;
Phytotherapy;
history
- From:
Chinese Journal of Natural Medicines (English Ed.)
2017;15(1):4-11
- CountryChina
- Language:English
-
Abstract:
In this review, we provide a comprehensive overview on the registration of proprietary Chinese medicines (PCMs) in China over the past century by examining published literature and historical data. We will examine this evolving administrative practice for PCMs registration in China, which is divided to the following five stages: (1) initial measures (1915-1948); (2) early development (1949-1965); (3) provincial approval and trial implementation of the "approval number" system (1966-1984); (4) legislation and cleanup (1985-1999); and (5) centralized national approval (2000 until now), offering a panoramic view on the characteristics of PCMs registration management in China.
